Overview

A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess steroid induced skin atrophy by sonography.
Phase:
Phase 1
Details
Lead Sponsor:
LEO Pharma
Treatments:
Betamethasone
Betamethasone benzoate
Betamethasone sodium phosphate
Betamethasone Valerate
Betamethasone-17,21-dipropionate
Clobetasol
Petrolatum